184 results on '"Dierks, Alexander"'
Search Results
2. Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer
3. Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT
4. [18F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
5. Granulomatous dermatitis: a rare pitfall in lymphoma staging with [18F]FDG-PET/CT
6. Sarcoidosis mimicking nodal manifestations of marginal zone lymphoma
7. [18F]FDG-PET/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma – A retrospective study
8. 177Lu-rhPSMA-10.1 Induces Tumor Response in a Patient With mCRPC After PSMA-Directed Radioligand Therapy With 177Lu-PSMA-I&T
9. Lung perfusion assessed by SPECT/CT after a minimum of three months anticoagulation therapy in patients with SARS-CoV-2-associated acute pulmonary embolism: a retrospective observational study
10. Color-coded summation images for the evaluation of blood flow in endovascular aortic dissection fenestration
11. Brand Purchase Funnel
12. C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [99mTc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study.
13. Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity – initial experience and comparison to [18F]FDG PET/CT and MRI
14. Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer.
15. First Safety and Efficacy Data with the Radiohybrid177Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer
16. Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT
17. Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 Patients with Medullary Thyroid Cancer
18. SSTR Antagonists as Theranostic Option in Small Cell Lung Cancer
19. Chapter B: From the traditional to a more nuanced brand purchase funnel
20. Chapter D: Discussion and outlook
21. Chapter C: Empirical application of a re-modeled brand purchase funnel
22. Chapter A: Changing consumer behavior as a challenge for brand management
23. Sekundärnutzung von Sozial- und Gesundheitsdaten – Rechtliche Rahmenbedingungen
24. First Safety and Efficacy Data with the Radiohybrid 177Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer.
25. Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 Patients with Medullary Thyroid Cancer.
26. Value of [18F]FDG PET/CT in Diagnosis and Management of Spondylodiscitis
27. An Intrapatient Dosimetry Comparison of177Lu-rhPSMA-10.1 and177Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
28. C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy of Multiple Myeloma Using [99mTc]Tc-PentixaTec
29. Brand Purchase Funnel
30. Somatostatin Receptor Antagonists as a Theranostic Option in Iodine-Refractory Thyroid Carcinoma
31. An Intrapatient Dosimetry Comparison of 177Lu-rhPSMA-10.1 and 177Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate Cancer.
32. Automatic covariance pattern analysis outperforms visual reading of 18F‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) in variant progressive supranuclear palsy.
33. Value of [18 F]FDG PET/CT in Diagnosis and Management of Spondylodiscitis.
34. In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target.
35. SSTR Antagonists as Theranostic Option in Merkel Cell Carcinoma.
36. Reduced splenic uptake on (68)Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis
37. [18F]FDG PET/CT guided biopsy confirms diagnosis of granulomatosis with polyangiitis
38. Tiger man sign in sarcoid myopathy
39. Re-Modeling the Brand Purchase Funnel
40. [18F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
41. Molecular Imaging in Multiple Myeloma—Novel PET Radiotracers Improve Patient Management and Guide Therapy
42. Reduced splenic uptake on 68Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis
43. A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma
44. Value of [18F]FDG PET/CT in diagnosis and management of spondylodiscitis
45. Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT.
46. Leveraging Growth Analytics for B2B Sales.
47. Reduced splenic uptake on 68Ga-Pentixafor-PET/CT imaging in multiple myeloma -- a potential imaging biomarker for disease prognosis.
48. 68Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms
49. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity
50. Metal artifact reduction by dual energy computed tomography using monoenergetic extrapolation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.